CTSZ mRNA expression in the blood was a molecular marker of high specificity and +LR for PCa in our cohort, with the potential to be helpful as a complementary biomarker to PSA to improve biopsy decision accuracy. Here, KLK3 is linked to posterior cortical atrophy.